Annovis to Highlight Buntanetap's Alzheimer's Research Progress with Presentations at CTAD 2024
October 22, 2024 08:00 ET
|
Annovis Bio, Inc.
MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies...